Epidarex Capital

Venture capital firm based in Edinburgh, UK

Latest Epidarex Capital investments

Epidarex Capital has invested in these startups.

Epsilogen

Epsilogen is revolutionizing cancer treatment with groundbreaking IgE antibodies and a £12.5 million boost in funding, propelling them towards a potential game-changer for patients battling solid tumors. Read more

Theolytics

Healthtech

Get ready for a groundbreaking biotechnology company in Oxford set to revolutionize cancer treatment with oncolytic viral therapies. Read more

Curve Therapeutics

Healthtech

Curve Therapeutics, backed by $40.5M in funding from industry giants like Pfizer Ventures, is revolutionizing drug discovery to tackle complex diseases and push the boundaries of biotechnology. Read more

Enterprise Therapeutics

Biotech

Brighton-based biopharmaceutical company Enterprise Therapeutics secures £26M in Series B funding, led by Panakes Partners, to accelerate the Phase 2a clinical trial of their lead program, ETD001, aiming to provide clinical proof of concept for treating cystic fibrosis and improve lung function. Read more

Harness Therapeutics

Biotech

Cambridge-based biotech company, Harness Therapeutics, secures an impressive £4 million in additional funding to advance its lead programme in targeting Huntington's Disease, bringing their total raised to £17.6 million. Read more

Investments By Sector

Epidarex Capital has invested in these sectors

Biotech	66.7%
Healthtech	33.3%

Venture Capital Investors

Connect with VC Investors from Epidarex Capital

They Have Invested With Epidarex Capital

Connect with investors related to Epidarex Capital's network

Advent Life Sciences

Columbus Venture Partners

M Ventures

Oxford Science Enterprises

List of pre-seed

& seed VC firms

2025 Startupmag.co.uk © Kohdao Ltd. Unit 8B Raleigh Gardens, Brixton, London, SW2 1AD, UK.
Registration 06261702. Data Protection No: ZA891746.